| Jennifer Campbell, RPH | |
|
1570 E Fairview Ave, Meridian, ID 83642-1821 | |
| (208) 888-0034 | |
| (208) 887-1332 |
| Full Name | Jennifer Campbell |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1570 E Fairview Ave, Meridian, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013553007 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P8457 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Campbell, RPH 575 W Elias St, Meridian, ID 83642-8127 Ph: (435) 680-1169 | Jennifer Campbell, RPH 1570 E Fairview Ave, Meridian, ID 83642-1821 Ph: (208) 888-0034 |
News Archive
"Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place," Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person's risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.
Medtronic, Inc. today announced the receipt of CE Mark (Conformité Européenne) and launch of the CapSure Sense MRI SureScan® pacing leads, which are approved for use during Magnetic Resonance Imaging (MRI). Medtronic introduced the first MR-Conditional pacemaker system in the world in 2008 and in the U.S. in 2011.
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia. The most recent Safety Monitoring Committee meeting of April 30, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 indicated no significant safety concerns for the trials to date.
At the invitation of the White House, The Children's Hospital of Philadelphia (CHOP) sent two special guests to President Barack Obama's announcement today of the Precision Medicine Initiative: Dr. Steven M. Altschuler, CHOP's chief executive officer, and 9-year-old patient Emily Whitehead, now cancer-free thanks to a personalized treatment called T cell therapy, developed at CHOP.
Two professions at opposite ends of the insurance business might not be thrilled with the health overhaul: Senior insurance company executives, and agents and brokers.
› Verified 6 days ago
Michael J Griffiths, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 208-706-5255 Fax: 208-706-5253 | |
Mark Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 N Main St, Meridian, ID 83642 Phone: 208-888-7311 | |
Gordon Riley Melvin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1570 E Fairview Ave, Meridian, ID 83642 Phone: 208-888-0034 | |
Mrs. Audrey Gyung Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 208-706-1523 Fax: 208-706-1543 | |
Judd Alan Durrant, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3250 S Eagle Rd, Meridian, ID 83642 Phone: 208-898-2543 | |
Kohner Warren, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 W Chinden Blvd, Meridian, ID 83646 Phone: 208-893-6033 |